Evidence map›Paper›PMID 38397735›Full record

ArticleAntioxidants (Basel, Switzerland)2024

Neuroprotection Afforded by an Enriched Mediterranean-like Diet Is Modified by Exercise in a Rat Male Model of Cerebral Ischemia.

Daniel Romaus-Sanjurjo, María Castañón-Apilánez, Esteban López-Arias, Antía Custodia, Cristina Martin-Martín, Alberto Ouro, Elena López-Cancio, Tomás Sobrino

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Lipid metabolism, microglia, and stroke.Neural regeneration research · 2026
    Article
  2. Review
  3. Current perspectives on the pathogenesis of cerebral atherosclerosis.Journal of inflammation (London, England) · 2025
    Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Daniel Romaus-SanjurjoNeuroAging Group (NEURAL), Clinical Neurosciences Research Laboratory (LINC), Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.ORCID 0000-0001-7715-1956
María Castañón-ApilánezDepartament of Neurology, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain.
Esteban López-AriasNeuroAging Group (NEURAL), Clinical Neurosciences Research Laboratory (LINC), Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.ORCID 0000-0002-0242-3600
Antía CustodiaNeuroAging Group (NEURAL), Clinical Neurosciences Research Laboratory (LINC), Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.ORCID 0000-0003-1122-0351
Cristina Martin-MartínTranslational Immmunology, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.
Alberto OuroNeuroAging Group (NEURAL), Clinical Neurosciences Research Laboratory (LINC), Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.ORCID 0000-0003-4359-1704
Elena López-CancioDepartament of Neurology, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain.ORCID 0000-0001-5757-9074
Tomás SobrinoNeuroAging Group (NEURAL), Clinical Neurosciences Research Laboratory (LINC), Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.ORCID 0000-0002-9760-8690
Instituto de Salud Carlos III · ESUniversidad de Oviedo · ESInstituto de Investigación Sanitaria del Principado de Asturias · ESInstituto de Investigación Sanitaria de Santiago · ES

Funding

Biomedical Research Networking Center on Neurodegenerative Diseases CB22/05/00067Instituto de Salud Carlos III CM19/00235Instituto de Salud Carlos III INT19/00075Instituto de Salud Carlos III PI18/01096Instituto de Salud Carlos III PI22/00938INTERREG Atlantic Area EAPA_791/2018_ NEUROATLANTIC projectINTER-REG V A España Portugal (POCTEP) 0624_2IQBIONEURO_6_EMarie Skłodowska-Curie Actions (MSCA) 101066444Ministerio de Ciencia e Innovación PDC2022-134000-I00Ministerio de Ciencia e Innovación RTC2019-007373-1Ministerio de Ciencia e Innovación RTI2018-102165-B-I00Xunta de Galicia IN606A-2021/015Xunta de Galicia IN607A2022/07Xunta de Galicia IN607D 2020/09
6 · The paper itself

Abstract

Ischemic stroke is an important cause of mortality and disability worldwide. Given that current treatments do not allow a remarkably better outcome in patients after stroke, it is mandatory to seek new approaches to preventing stroke and/or complementing the current treatments or ameliorating the ischemic insult. Multiple preclinical and clinical studies highlighted the potential beneficial roles of exercise and a Mediterranean diet following a stroke. Here, we investigated the effects of a pre-stroke Mediterranean-like diet supplemented with hydroxytyrosol and with/without physical exercise on male rats undergoing transient middle cerebral artery occlusion (tMCAO). We also assessed a potential synergistic effect with physical exercise. Our findings indicated that the diet reduced infarct and edema volumes, modulated acute immune response by altering cytokine and chemokine levels, decreased oxidative stress, and improved acute functional recovery post-ischemic injury. Interestingly, while physical exercise alone improved certain outcomes compared to control animals, it did not enhance, and in some aspects even impaired, the positive effects of the Mediterranean-like diet in the short term. Overall, these data provide the first preclinical evidence that a preemptive enriched Mediterranean diet modulates cytokines/chemokines levels downwards which eventually has an important role during the acute phase following ischemic damage, likely mediating neuroprotection.

Indexed as

cerebral ischemiaEPCsexercisehydroxytyrosolinflammationmediterranean dietmicrogliaMilliplexneuroprotectiontMCAO

Identifiers

PMID38397735
PMCPMC10885962
OpenAlexW4391135982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.